Stockreport

The Hydroxychloroquine Debate–As The U.S. Orders 29 Million Doses, Initial Champion France Remains Divided Over Its Efficacy [Forbes]

New York Times Company (The)  (NYT) 
Last new york times company (the) earnings: 2/6 07:00 am Check Earnings Report
US:NYSE Investor Relations: investors.nytco.com/investors/default.aspx
PDF The debate over usinghydroxychloroquine to treat COVID-19 patients rages on, particularly as news emerged that President Trump has stockpiled 29 million doses. The main [Read more]